Skip to content
2000
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

The oral route is the most typical way to provide medication due to its benefits, including non-invasiveness, patient compliance, and ease of medication delivery. One of the most often recommended pharmacological groups for the treatment of pain and inflammatory disease is non-steroidal anti-inflammatory medicines. However, the major side effect of non-steroidal anti-inflammatory medicines is PUD (peptic ulcer disease). An imbalance in the action of gastroprotective and aggressive agents causes gastric ulcers. Gastroprotective mechanisms include the mucus layer, mucosal repair capacity, gastric epithelium, and gastric blood flow. The purpose of this review is to provide an update on gastroprotective mechanisms. As discussed, mucin acts as a filter, and gastric epithelial defenses include the cell barrier, stem cells, and a sensor on the mucosal surface.

© 2023 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/2210299X01666230522145303
2023-08-01
2025-10-03

  • From This Site

    /content/journals/cis/10.2174/2210299X01666230522145303
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/1/1/CIS-1-E220523217196.html?itemId=/content/journals/cis/10.2174/2210299X01666230522145303&mimeType=html&fmt=ahah

References

  1. CostaM. All together now: From pacemakers to gastric peristalsis.J. Physiol.20065711110.1113/jphysiol.2005.10437216410277
     [Google Scholar]
  2. AtumaC. StrugalaV. AllenA. HolmL. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo.Am. J. Physiol. Gastrointest. Liver Physiol.20012805G922G92910.1152/ajpgi.2001.280.5.G92211292601
     [Google Scholar]
  3. JohanssonM.E.V. PhillipsonM. PeterssonJ. VelcichA. HolmL. HanssonG.C. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria.Proc. Natl. Acad. Sci.200810539150641506910.1073/pnas.080312410518806221
     [Google Scholar]
  4. MadushaniH. SuzanneH. JoelC.B. AshleyE.F. Hill-YardinE.L. SinghT.P. The role of the gastrointestinal mucus system in intestinal homeostasis: Implications for neurological disorders.Front. Cell. Infect. Microbiol202011325
     [Google Scholar]
  5. SinhaM. GautamL. ShuklaP.K. KaurP. SharmaS. SinghT.P. Current perspectives in NSAID-induced gastropathy.Mediators Inflamm20132013258209
     [Google Scholar]
  6. DeRuiterJ. Non-steroidal antiinflammatory drugs (NSAIDS).Principles of Drug Action20022125
     [Google Scholar]
  7. VaneJ.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.Nat. New Biol.19712312523223510.1038/newbio231232a05284360
     [Google Scholar]
  8. SaverymuttuS.H. ThomasA. GrundyA. MaxwellJ.D. Ileal stricturing after long-term indomethacin treatment.Postgrad. Med. J.19866273296796810.1136/pgmj.62.732.9673774733
     [Google Scholar]
  9. WallaceJ.L. GrangerD.N. The cellular and molecular basis of gastric mucosal defense.FASEB J.199610773174010.1096/fasebj.10.7.86356908635690
     [Google Scholar]
  10. JohnJ.L. Prostaglandins, NSAIDs, and gastric mucosal protection: Why doesn’t the stomach digest itself.Physiol Rev.1548881548
     [Google Scholar]
  11. GiannellaR.A. BroitmanS.A. ZamcheckN. Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective.Ann. Intern. Med.197378227127610.7326/0003‑4819‑78‑2‑2714567180
     [Google Scholar]
  12. GrayJ.D. ShinerM. Influence of gastric pH on gastric and jejunal flora.Gut19678657458110.1136/gut.8.6.5744865576
     [Google Scholar]
  13. ForstnerJ.F. Intestinal mucins in health and disease.Digestion197817323426310.1159/00019811525218
     [Google Scholar]
  14. WalshJ.H. PetersonW.L. The treatment of helicobacter pylori infection in the management of peptic ulcer disease.N. Engl. J. Med.19953331598499110.1056/NEJM1995101233315087666920
     [Google Scholar]
  15. AllenA Flemstro¨mG. Gastroduodenal mucus bicarbonate barrier: Protection against acid and pepsin.Am J Physiol Cell Physiol20052881C11910.1152/ajpcell.00102.2004
     [Google Scholar]
  16. HoS.B. TakamuraK. AnwayR. ShekelsL.L. ToribaraN.W. OtaH. The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins.Dig. Dis. Sci.200449101598160610.1023/B:DDAS.0000043371.12671.9815573912
     [Google Scholar]
  17. BahariH.M. RossI.N. TurnbergL.A. Demonstration of a pH gradient across the mucus layer on the surface of human gastric mucosa in vitro. Gut198223651351610.1136/gut.23.6.5137076026
     [Google Scholar]
  18. SchreiberS. ScheidP. Gastric mucus of the guinea pig: Proton carrier and diffusion barrier.Am. J. Physiol.19972721 Pt 1G63G709038877
     [Google Scholar]
  19. BaumgartnerH.K. MontroseM.H. Regulated alkali secretion acts in tandem with unstirred layers to regulate mouse gastric surface pH.Gastroenterology126377478310.1053/j.gastro.2003.11.05914988832
     [Google Scholar]
  20. BjörneH. PeterssonJ. PhillipsonM. WeitzbergE. HolmL. LundbergJ.O. Nitrite in saliva increases gastric mucosal blood flow and mucus thickness.J. Clin. Invest.2004113110611410.1172/JCI1901914702114
     [Google Scholar]
  21. GoddardP.J. KaoY.C.J. LichtenbergerL.M. Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel.Gastroenterology199098236137010.1016/0016‑5085(90)90826‑M2295391
     [Google Scholar]
  22. LichtenbergerL.M. The hydrophobic barrier properties of gastrointestinal mucus.Annu. Rev. Physiol.199557156558310.1146/annurev.ph.57.030195.0030257778878
     [Google Scholar]
  23. WallaceJ.L. Gastric resistance to acid: Is the “mucus-bicarbonate barrier” functionally redundant?Am. J. Physiol.19892561 Pt 1G31G382492159
     [Google Scholar]
  24. SandersM.J. AyalonA. RollM. SollA.H. The apical surface of canine chief cell monolayers resists Hback-diffusion.Nature•••31319855154
     [Google Scholar]
  25. WrightN.A. Role of mucosal cell renewal in mucosal protection in the gastrointestinal tract.Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. AllenA. FlemstromC. GamerA. SilenW. TurnbergL.A. New YorkRaven19841520
     [Google Scholar]
  26. HardingR.K. MorrisG.P. Cell loss from normal and stressed gastric mucosae of the rat. An ultrastructural analysis.Gastroenterology197772585786310.1016/S0016‑5085(77)80200‑X849816
     [Google Scholar]
  27. GislasonH. SørbyeH. Abdi-DezfuliF. WaldumH.L. SvanesK. Role of prostaglandins and histamine in hyperemic response to superficial and deep gastric mucosal injury and H+ back-diffusion in cats.Dig. Dis. Sci.19954081669167810.1007/BF022126877648966
     [Google Scholar]
  28. HolzerP. SametzW. Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferentneurons.Gastroenterology1986911986975981
     [Google Scholar]
  29. BeckP.L. McKnightW. LeeS.S. WallaceJ.L. Prostaglandin modulation of the gastric vasculature and mucosal integrity in cirrhotic rats.Am. J. Physiol.19932653 Pt 1G453G4588214067
     [Google Scholar]
  30. WrightN.A. PikeC. EliaG. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells.Nature19903436253828510.1038/343082a02296294
     [Google Scholar]
  31. MaL. ElliottS.N. CirinoG. BuretA. IgnarroL.J. WallaceJ.L. Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release.Proc. Natl. Acad. Sci.200198116470647510.1073/pnas.11115079811353854
     [Google Scholar]
  32. GreenFW KaplanMM CurtisLE LevinePH Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage.Astroenterology1978743843
     [Google Scholar]
  33. GreenFW Harsh Mohan textbook of Pathology7th editionNew Delhi London Philadelphia PanamaHealth Sciences publishers2015
     [Google Scholar]
  34. Harrison's Principles of Internal Medicine Casper Fouzia Sir longo Jameson loscalzoMcgraw Hill education2015
     [Google Scholar]
  35. Robbins basic pathology9th ed.Elsevier2016564566
     [Google Scholar]
  36. Reference davidson's principle and practice of medicine 22 MD 2014Elsevier2014
     [Google Scholar]
  37. Gastritis medical physiology7th ed.The Health Sciences publishersNew Delhi London2013
     [Google Scholar]
  38. VaibhavS. VidyasagarG. ShyamlilaB.B. NandkishorB. Management of peptic ulcer-a review.IJIRT2020612
     [Google Scholar]
  39. TakeshiK. Who needs gastroprotection in 2020.Curr Treat Options Gastro202018557573
     [Google Scholar]
  40. LapennaD. De GioiaS. MezzettiA. GrossiL. FestiD. MarzioL. CuccurulloF. H 2 -receptor antagonists are scavengers of oxygen radicals.Eur. J. Clin. Invest.199424747648110.1111/j.1365‑2362.1994.tb02378.x7957505
     [Google Scholar]
  41. RobinsonM.G. GriffinJ.W.Jr BowersJ. KoganF.J. KogutD.G. LanzaF.L. WarnerC.W. Effect of ranitidine gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs.Dig. Dis. Sci.198934342442810.1007/BF015362662646087
     [Google Scholar]
  42. EhsanullahR.S. PageM.C. TildesleyG. WoodJ.R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.BMJ198829766551017102110.1136/bmj.297.6655.10173142593
     [Google Scholar]
  43. WolfeM.M. LichtensteinD.R. SinghG. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.N. Engl. J. Med.1999340241888189910.1056/NEJM19990617340240710369853
     [Google Scholar]
  44. BellN.J. HuntR.H. Progress with proton pump inhibition.Yale J. Biol. Med.19926566496571341069
     [Google Scholar]
  45. WuK.K. Cyclooxygenase 2 induction: Molecular mechanism and pathophysiologic roles.J. Lab. Clin. Med.1996128324224510.1016/S0022‑2143(96)90023‑28783630
     [Google Scholar]
  46. BombardierC. LaineL. ReicinA. ShapiroD. Burgos-VargasR. DavisB. DayR. FerrazM.B. HawkeyC.J. HochbergM.C. KvienT.K. SchnitzerT.J. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.N. Engl. J. Med.2000343211520152810.1056/NEJM20001123343210311087881
     [Google Scholar]
  47. SaavedraJ.E. BilliarT.R. WilliamsD.L. KimY.M. WatkinsS.C. KeeferL.K. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver.J. Med. Chem.199740131947195410.1021/jm97010319207935
     [Google Scholar]
  48. KonturekS.J. BrzozowskiT. MajkaJ. SzlachcicA. Pytko-PolonczykJ. Implications of nitric oxide in the action of cytoprotective drugs on gastric mucosa.J. Clin. Gastroenterol.199317S1S140S14510.1097/00004836‑199312001‑000258283009
     [Google Scholar]
  49. WallaceJ.L. MillerM.J.S. Nitric oxide in mucosal defense: A little goes a long way.Gastroenterology2000119251252010.1053/gast.2000.930410930387
     [Google Scholar]
  50. FiorucciS. AntonelliE. MencarelliA. OrlandiS. RengaB. RizzoG. DistruttiE. ShahV. MorelliA. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis.Hepatology200542353954810.1002/hep.2081716108046
     [Google Scholar]
  51. LichtenbergerL.M. BarronM. MarathiU. Association of phosphatidylcholine and nsaids as a novel strategy to reduce gastrointestinal toxixity.Drugs Today2009451287789010.1358/dot.2009.45.12.144107520135022
     [Google Scholar]
  52. Gastroprotective Agent definitionAvailable from: https://www.lawinsider.com/dictionary/gastroprotective agent#:~:text=Gastroprotective%20Agent%20means%20proton%20pump,injury%20to
  53. SaschaD. RodL.W. MichaelL.J. JenniferC.N. NoelS.W. LisaA.J. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: A population-based case-control study.Pharmacoepidemiol Drug Saf.2010198792802
     [Google Scholar]
  54. ZidarN. OdarK. GlavacD. JerseM. ZupancT. StajerD. Cyclooxygenase in normal human tissues - is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?J. Cell. Mol. Med.2009139b3753376310.1111/j.1582‑4934.2008.00430.x18657230
     [Google Scholar]
  55. GudisK. SakamotoC. The role of cyclooxygenase in gastric mucosal protection.Dig. Dis. Sci.200550S1S16S2310.1007/s10620‑005‑2802‑716184416
     [Google Scholar]
  56. KonturekS.J. KonturekP.C. PawlikT. SliwowskiZ. OchmańskiW. HahnE.G. Duodenal mucosal protection by bicarbonate secretion and its mechanisms.J. Physiol. Pharmacol.200455S251715608357
     [Google Scholar]
  57. SeibertK. ZhangY. LeahyK. HauserS. MasferrerJ. PerkinsW. LeeL. IsaksonP. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.Proc. Natl. Acad. Sci.19949125120131201710.1073/pnas.91.25.120137991575
     [Google Scholar]
  58. SeibertK. MasferrerJ.L. Role of inducible cyclooxygenase (COX-2) in inflammation.Receptor19944117238038702
     [Google Scholar]
  59. MitchellJ.A. AkarasereenontP. ThiemermannC. FlowerR.J. VaneJ.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.Proc. Natl. Acad. Sci.19939024116931169710.1073/pnas.90.24.116938265610
     [Google Scholar]
  60. MillerT. A. Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms.Am. J. Physiol. Cell Physiol.19832455G601G62310.1152/ajpgi.1983.245.5.G601
     [Google Scholar]
  61. SomasundaramS. RafiS. HayllarJ. SigthorssonG. JacobM. PriceA.B. MacphersonA. MahmodT. ScottD. WrigglesworthJ.M. BjarnasonI. Mitochondrial damage: A possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine.Gut199741334435310.1136/gut.41.3.3449378390
     [Google Scholar]
  62. TomisatoW. TanakaK. KatsuT. KakutaH. SasakiK. TsutsumiS. HoshinoT. AburayaM. LiD. TsuchiyaT. SuzukiK. YokomizoK. MizushimaT. Membrane permeabilization by non-steroidal anti-inflammatory drugs.Biochem. Biophys. Res. Commun.200432331032103910.1016/j.bbrc.2004.08.20515381103
     [Google Scholar]
  63. AnticoagulantsAvailable from: https://www.medicinenet.com/anticoagulants_drug_class_of_blood_thinners/article.htm
  64. ZhengH.M. ChoiM.J. KimJ.M. ChaK.H. LeeK.W. ParkY.H. HongS.S. LeeD.H. Centella asiatica leaf extract protects against indomethacin-induced gastric mucosal injury in rats.J. Med. Food2016191384610.1089/jmf.2015.346426469560
     [Google Scholar]
  65. GohilK. PatelJ. GajjarA. Pharmacological review on Centella asiatica: A potential herbal cure-all.Indian J. Pharm. Sci.201072554655610.4103/0250‑474X.7851921694984
     [Google Scholar]
  66. CestariS.H. BastosJ.K. Di StasiL.C. Intestinal anti-inflammatory activity of Baccharis dracunculifolia in the trinitrobenzenesulphonic acid model of rat colitis.Evid. Based Complement. Alternat. Med.201120111910.1093/ecam/nep08119592480
     [Google Scholar]
  67. MassignaniJ.J. LemosM. MaistroE.L. SchaphauserH.P. JorgeR.F. SousaJ.P.B. BastosJ.K. de AndradeS.F. Antiulcerogenic activity of the essential oil of Baccharis dracunculifolia on different experimental models in rats.Phytother. Res.200923101355136010.1002/ptr.262419274697
     [Google Scholar]
  68. BiondoT.M.A. TanaeM.M. ColettaE.D. Lima-LandmanM.T.R. LapaA.J. SouccarC. Antisecretory actions of Baccharis trimera (Less.) DC aqueous extract and isolated compounds: Analysis of underlying mechanisms.J. Ethnopharmacol.2011136236837310.1016/j.jep.2011.04.06521575703
     [Google Scholar]
  69. NegiP. GautamS. SharmaA. RathoreC. SharmaL. UpadhyayN. TambuwalaM.M. ChellappanD.K. GuptaG. PrasherP. DuaK. AgarwalS. LalU.R. Gastric ulcer healing by chebulinic acid solid dispersion-loaded gastroretentive raft systems: preclinical evidence.Ther. Deliv.2022132819310.4155/tde‑2021‑006235075915
     [Google Scholar]
  70. RuwartM.J. NezamisJ.E. RushB.D. LancasterC. DavisJ.P. NicholsN.M. Timoprazole is a unique cytoprotective agent in the rat.Digestion19843013340
     [Google Scholar]
  71. LindbergP. BrändströmA. WallmarkB. MattssonH. RiknerL. HoffmannK.J. Omeprazole: The first proton pump inhibitor.Med. Res. Rev.199010115410.1002/med.26101001022404184
     [Google Scholar]
  72. StedmanC.A.M. BarclayM.L. Review article: Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.Aliment. Pharmacol. Ther.200014896397810.1046/j.1365‑2036.2000.00788.x10930890
     [Google Scholar]
  73. Histamine Type-2 Receptor Antagonists (H2 Blockers).LiverTox: Clinical and Research Information on Drug-Induced Liver InjuryBethesda (MD)National Institute of Diabetes and Digestive and Kidney Diseases
     [Google Scholar]
  74. AntacidAvailable from: https://my.clevelandclinic.org/health/drugs/23076-antacid#:~:text=Antacids%20are%20a%20medicine%20that,the%2Dcounter%20without%20a%20prescription
  75. NSAIDs: Non-steroidal anti-inflammatory drugs.Available from: https://www.spine-health.com/treatment/pain-medication/understanding-cox-2-inhibitor-side-effects
  76. De Toledo DiasL.F. de MeloE.S. HernandesL.S. BacchiE.M. Antiulcerogenic and antioxidant activities of Baccharis trimera (Less) DC (Asteraceae) Revista Brasileira De Farmacognosia-Brazilian.J. Pharm.200919309314
     [Google Scholar]
  77. dos Reis LíveroF.A. da SilvaL.M. FerreiraD.M. GaluppoL.F. BoratoD.G. PrandoT.B.L. LourençoE.L.B. StrapassonR.L.B. StefanelloM.É.A. de Paula WernerM.F. AccoA. Hydroethanolic extract of Baccharis trimera promotes gastroprotection and healing of acute and chronic gastric ulcers induced by ethanol and acetic acid.Naunyn Schmiedebergs Arch. Pharmacol.2016389998599810.1007/s00210‑016‑1262‑227314669
     [Google Scholar]
  78. PetrovićS. DobrićS. Mimica-DukićN. SiminN. KukićJ. NiketićM. The antiinflammatory, gastroprotective and antioxidant activities of Hieracium gymnocephalum extract.Phytother. Res.200822111548155110.1002/ptr.248518814212
     [Google Scholar]
  79. PetrovicS.D. DobricS. BokonjicD. NiketicM. García-PiñeresA. MerfortI. Evaluation of Tanacetum larvatum for an anti-inflammatory activity and for the protection against indomethacin-induced ulcerogenesis in rats.J. Ethnopharmacol.200387110911310.1016/S0378‑8741(03)00118‑112787963
     [Google Scholar]
  80. BoeingT. da SilvaL.M. SomensiL.B. CuryB.J. Michels CostaA.P. PetreanuM. NieroR. de AndradeS.F. Antiulcer mechanisms of Vernonia condensata Baker: A medicinal plant used in the treatment of gastritis and gastric ulcer.J. Ethnopharmacol.201618419620710.1016/j.jep.2016.02.04926956376
     [Google Scholar]
  81. FrutuosoV. GurjãoM. CordeiroR. MartinsM. Analgesic and anti-ulcerogenic effects of a polar extract from leaves of Vernonia condensata. Planta Med.1994601212510.1055/s‑2006‑9594008134411
     [Google Scholar]
  82. de BarrosM. Mota da SilvaL. BoeingT. SomensiL.B. CuryB.J. de Moura BurciL. SantinJ.R. de AndradeS.F. MonacheF.D. Cechinel-FilhoV. Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents.Naunyn Schmiedebergs Arch. Pharmacol.2016389440341710.1007/s00210‑015‑1208‑026758066
     [Google Scholar]
  83. BucciarelliA. MinettiA. MilczakowskygC. SkliarM. Evaluation of gastroprotective activity and acute toxicity of Solidago chilensis Meyen (Asteraceae).Pharm. Biol.20104891025103010.3109/1388020090345313120731555
     [Google Scholar]
  84. GanjareA.B. NirmalS.A. RubR.A. PatilA.N. PattanS.R. Use of Cordia dichotoma bark in the treatment of ulcerative colitis.Pharm. Biol.201149885085510.3109/13880209.2010.55153921696332
     [Google Scholar]
  85. SiniK.R. SinhaB.N. RajasekaranA. Protective effects of Capparis zeylanica Linn. Leaf extract on gastric lesions in experimental animals.Avicenna J. Med. Biotechnol.201131313523407576
     [Google Scholar]
  86. DebnathS. BiswasD. RayK. GuhaD. Moringa oleifera induced potentiation of serotonin release by 5-HT3 receptors in experimental ulcer model.Phytomedicine2011182-3919510.1016/j.phymed.2010.06.00320637582
     [Google Scholar]
  87. ChoudharyM.K. BodakheS.H. GuptaS.K. Assessment of the antiulcer potential of Moringa oleifera root-bark extract in rats.J. Acupunct. Meridian Stud.20136421422010.1016/j.jams.2013.07.00323972244
     [Google Scholar]
  88. MinaiyanM. AsghariG. TaheriD. SaeidiM. Nasr-EsfahaniS. Anti-inflammatory effect of Moringa oleifera Lam. seeds on acetic acid-induced acute colitis in rats.Avicenna J. Phytomed.20144212713625050310
     [Google Scholar]
  89. MishraV. AgrawalM. OnasanwoS.A. MadhurG. RastogiP. PandeyH.P. PalitG. NarenderT. Anti-secretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers.Phytomedicine201320650651110.1016/j.phymed.2013.01.002
     [Google Scholar]
  90. Available from: https://www.researchgate.net/figure/Shows-different-gastroprotective-agents_tbl2_274654804
  91. Antiulcer Agents.LiverTox: Clinical and Research Information on Drug-Induced Liver InjuryBethesda (MD)National Institute of Diabetes and Digestive and Kidney Diseases31643339
     [Google Scholar]
  92. Everything You Want to Know About Prostaglandins.Available from: https://www.healthline.com/health/prostaglandins#what-they-do
  93. Prokinetic agent.Available from: https://en.wikipedia.org/wiki/Prokinetic_agent#:~:text=A%20prokinetic%20agent%20
  94. HenryI.J. Gastric Emptying.Reference Module in Biomedical Sciences201710.1016/B978‑0‑12‑801238‑3.64921‑8
     [Google Scholar]
  95. ChoungR.S. TalleyN.J. PetersonJ. CamilleriM. BurtonD. HarmsenW.S. ZinsmeisterA.R. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.Neurogastroenterol. Motil.200719318018710.1111/j.1365‑2982.2006.00869.x17300287
     [Google Scholar]
  96. LundellL. MyersJ.C. JamiesonG.G. Is motility impaired in the entire upper gastrointestinal tract in patients with gastro-oesophageal reflux disease?Scand. J. Gastroenterol.199631213113510.3109/003655296090319768658034
     [Google Scholar]
/content/journals/cis/10.2174/2210299X01666230522145303
Loading
A Review on Gastroprotective Mechanisms and their Augmentation by External Agents
Curr. Indian Sci. 1, E220523217196 (2023); https://doi.org/10.2174/2210299X01666230522145303
/content/journals/cis/10.2174/2210299X01666230522145303
/content/journals/cis/10.2174/2210299X01666230522145303
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Gastroprotective; Luminal irritants; Mucosal injury; Mucosal surface; Non-steroidal anti-inflammatory medicines; Peptic ulcer disease

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test